BSEAbate As Industries LtdMediumPositive
Announced Tue, 24 Mar · 15:01 IST

Disclosure under Regulation 30 of SEBI (LODR) Regulations 2015

Business Updates View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+5.7%1-day move
₹11.15
prior close
₹11.13
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.6-0.5+2.5+5.7+3.9-0.1+3.1+3.1+1.2+2.7-1.5-8.1-9.2
Up moveDown movePending
AI summary

Abate AS Industries Ltd, through its healthcare subsidiary Abate Eye Hospital, has launched Kerala's first Alcon Vision Suite (AVS), a fully integrated digital ecosystem for ophthalmic care. The system covers the entire patient journey from diagnosis and surgical planning to surgery and post-operative recovery, featuring the NGENUITY 1.5 3D Visualization System and ADi digital surgical planning platform. The company describes this as a significant technological leap for the region, enabling more precise cataract and glaucoma surgeries and positioning the hospital as a center of excellence for training young ophthalmologists. The filing itself is a voluntary disclosure under SEBI LODR Regulation 30, submitted alongside a press release dated 24 March 2026.

Likely market impact

For shareholders, this is a capability-building and brand-positioning move rather than a revenue-triggering event — no financial figures, order values, or revenue impact are disclosed. It could support long-term patient growth and premium pricing, but offers no immediate catalyst for the stock price.